Ophthalmology Consultants, Ltd. Report issue

Academic/Hospital Phase 1 Phase 4

Organization Overview

First Clinical Trial
2010
NCT01455233
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Opthalmology Consultants Ltd

Active Ingredients

Drugs in Phase 4 Trials (2)

besifloxacin (besivance) (1 trial)

moxifloxacin (avelox) (1 trial)

Drugs in Phase 1 Trials (1)

levofloxacin (levaquin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cataract (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3